HCWB · HCW Biologics Inc. · Exempt Offerings
$1.57
-0.07 (-4.27%)
At close · Oct 6
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company believes that substantial doubt exists regarding its ability to continue as a going concern for at least 12 months from the date of issuance of the Company's condensed financial statements, without additional funding or financial support. After considering management's plan for financing and funds raised that are probable to occur within one year, as well as that the Company expects to continue to incur losses from operations for the foreseeable future, management concluded that the substantial doubt that existed in its going concern analysis as of June 30, 2026 was not alleviated.”View the 10-Q filed Aug 14, 2026
Market Cap
$3.54M
Shares
1.84M
Volume · Oct 6
37.72K
Avg daily vol (3M)
371.87K
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2026-08-06 | New | Biotechnology | $1,600,000 | $1,600,000 | 06b |
| 2026-06-08 | New | Biotechnology | $4,000,000 | $4,000,000 | 06b |
| 2024-12-05 | New | Biotechnology | $6,918,254 | $6,918,254 | 06b |
| 2024-02-27 | New | Biotechnology | $2,500,005 | $2,500,005 | 06b |
| 2020-10-19 | New | Biotechnology | $16,000,000 | $6,168,320 | 06b |
Showing 1–5 of 5 filings